Premium
Antibodies to β 1 ‐integrins cause alterations of aortic vasculogenesis, in vivo
Author(s) -
Drake Christopher J.,
Davis Lynn A.,
Little Charles D.
Publication year - 1992
Publication title -
developmental dynamics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.634
H-Index - 141
eISSN - 1097-0177
pISSN - 1058-8388
DOI - 10.1002/aja.1001930111
Subject(s) - vasculogenesis , quail , biology , integrin , mesoderm , microbiology and biotechnology , angiogenesis , extracellular matrix , anatomy , immunology , endocrinology , embryonic stem cell , cell , biochemistry , cancer research , stem cell , progenitor cell , gene
Abstract Vasculogenesis is the de novo formation of blood vessels from mesoderm. This process occurs very early in development and provides a convenient system for studying morphogenesis in higher vertebrates. The cell‐extracellular matrix (ECM) interactions that occur during dorsal aortic vasculogenesis were examined using the monoclonal antibody, CSAT, a reagent known to neutralize the ligand‐binding activity of avian β 1 ‐integrins. We injected CSAT into quail embryos during a period of active vasculogenesis (4–10 somites). The CSAT antibodies, but not controls, had a marked and reproducible effect on aortic vessel formation. Vasculogenesis appeared to be arrested at the stage when slender cord‐like assemblies of angioblasts rearrange to form tubules. Indeed, aortic primordia near the site of CSAT injection did not form patent vessels.